FOLH1 and central nervous system neoplasm: The surreptitious discovery of the utility of PSMA-targeted PET imaging in CNS tumors has invigorated much excitement in the field about its potential clinical application, but more research is needed to better understand this PET tracer before it can be implemented clinically.